Yeaman Kevin J's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Oct 13, 2021
- Accession no.
- 0001209191-21-060398
- Filed
- Oct 13, 2021
- Trade date
- Oct 12, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.58M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yeaman Kevin JCIK 0001200469 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Class A Common Stock | MOption exerciseAcquired | +14,730 | $37.35 | +$550,165.5 | 47,625 | Indirect | |
| Oct 12, 2021 | Class A Common Stock | SSaleDisposed | −14,730 | $87.56F1 | −$1,289,758.8 | 32,895 | Indirect | |
| Oct 12, 2021 | Class A Common Stock | MOption exerciseAcquired | +14,727 | $42.98 | +$632,966.46 | 47,622 | Indirect | |
| Oct 12, 2021 | Class A Common Stock | SSaleDisposed | −14,727 | $87.50F2 | −$1,288,612.5 | 32,895 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Class A Common Stock | MOption exerciseDisposed | −14,730 | $0.00 | $0 | 0 | Indirect | |
| Oct 12, 2021 | Class A Common Stock | MOption exerciseDisposed | −14,727 | $0.00 | $0 | 276,871 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were sold in multiple transactions at prices ranging from $87.13 to $87.905, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F2
The shares were sold in multiple transactions at prices ranging from $87.13 to $87.905 inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**